Representative Jonathan L. Jackson (Democratic-Illinois) recently sold shares of McKesson Corporation (NYSE:MCK). In a filing disclosed on July 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in McKesson stock on June 15th. The trade occurred in the Representative’s “MORGAN STANLEY – ROLLOVER IRA” account.
Representative Jonathan L. Jackson also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Hilton Worldwide (NYSE:HLT) on 6/15/2026.
- Purchased $1,001 – $15,000 in shares of Sphere Entertainment (NYSE:SPHR) on 6/15/2026.
- Sold $15,001 – $50,000 in shares of Microsoft (NASDAQ:MSFT) on 5/12/2026.
- Sold $50,001 – $100,000 in shares of Visa (NYSE:V) on 4/24/2026.
- Sold $1,001 – $15,000 in shares of O’Reilly Automotive (NASDAQ:ORLY) on 4/24/2026.
- Sold $15,001 – $50,000 in shares of Tenet Healthcare (NYSE:THC) on 4/20/2026.
- Purchased $15,001 – $50,000 in shares of Simon Property Group (NYSE:SPG) on 4/20/2026.
McKesson Stock Up 0.1%
Shares of NYSE MCK traded up $0.83 during trading on Friday, hitting $842.14. 1,118,598 shares of the company traded hands, compared to its average volume of 1,050,718. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00. The company has a 50-day moving average price of $771.33 and a 200-day moving average price of $838.33. The firm has a market capitalization of $98.60 billion, a P/E ratio of 21.89, a P/E/G ratio of 1.38 and a beta of 0.31.
McKesson Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st were issued a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date was Monday, June 1st. McKesson’s dividend payout ratio (DPR) is 8.53%.
Institutional Investors Weigh In On McKesson
Several hedge funds and other institutional investors have recently bought and sold shares of the business. University of Texas Texas AM Investment Management Co. acquired a new stake in McKesson during the fourth quarter valued at approximately $25,000. Swiss RE Ltd. acquired a new position in shares of McKesson in the 4th quarter worth approximately $26,000. State of Wyoming bought a new stake in shares of McKesson in the 2nd quarter valued at approximately $29,000. Vermillion & White Wealth Management Group LLC bought a new stake in shares of McKesson in the 3rd quarter valued at approximately $33,000. Finally, Board of the Pension Protection Fund acquired a new stake in shares of McKesson during the 4th quarter valued at approximately $33,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
MCK has been the topic of several research reports. Citigroup cut their price target on shares of McKesson from $975.00 to $945.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Wall Street Zen downgraded shares of McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, June 27th. JPMorgan Chase & Co. cut their target price on shares of McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating on the stock in a research note on Friday, May 8th. Wells Fargo & Company reduced their target price on shares of McKesson from $925.00 to $812.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 12th. Finally, Barclays lowered their price target on McKesson from $1,050.00 to $925.00 and set an “overweight” rating for the company in a report on Wednesday, June 10th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $960.53.
View Our Latest Stock Analysis on McKesson
Insider Transactions at McKesson
In related news, CAO Napoleon B. Rutledge, Jr. sold 133 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $764.00, for a total value of $101,612.00. Following the completion of the transaction, the chief accounting officer directly owned 632 shares of the company’s stock, valued at $482,848. This represents a 17.39% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Thomas L. Rodgers sold 2,388 shares of the firm’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total value of $1,817,482.92. Following the transaction, the executive vice president directly owned 3,090 shares in the company, valued at $2,351,768.10. This trade represents a 43.59% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 28,748 shares of company stock valued at $22,262,035. Company insiders own 0.06% of the company’s stock.
About Representative Jackson
Jonathan Jackson (Democratic Party) is a member of the U.S. House, representing Illinois’ 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.
Jackson (Democratic Party) is running for re-election to the U.S. House to represent Illinois’ 1st Congressional District. He declared candidacy for the 2026 election.
Jonathan Jackson was born in Chicago, Illinois. Jackson graduated from Whitney Young High School. He earned an M.B.A. from Northwestern University. Jackson’s career experience includes working as an investment analyst and an entrepreneur.
McKesson Company Profile
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Further Reading
- Five stocks we like better than McKesson
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
